<SEC-DOCUMENT>0001193125-19-219029.txt : 20190812
<SEC-HEADER>0001193125-19-219029.hdr.sgml : 20190812
<ACCEPTANCE-DATETIME>20190812162203
ACCESSION NUMBER:		0001193125-19-219029
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20190808
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190812
DATE AS OF CHANGE:		20190812

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		191016795

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d790557d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://www.cvshealth.com/20190808" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Form 8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="d_2019-08-08_to_2019-08-08">CVS HEALTH Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="d_2019-08-08_to_2019-08-08">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="d_2019-08-08_to_2019-08-08">0000064803</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="cvs-20190808.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="d_2019-08-08_to_2019-08-08"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2019-08-08</xbrli:startDate> <xbrli:endDate>2019-08-08</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="font-size:10pt;width:8.5in;margin:0 auto"> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <p style="margin-bottom:0px;margin-top:4pt"></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">UNITED STATES</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0pt;margin-top:0pt">SECURITIES AND EXCHANGE COMMISSION</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Washington, D.C. 20549</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:18pt;margin-bottom:0px;margin-top:12pt">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="d_2019-08-08_to_2019-08-08">8-K</ix:nonNumeric> </span></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:12pt">CURRENT REPORT</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">Pursuant to Section&#160;13 OR 15(d)</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">of The Securities Exchange Act of 1934</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:12pt;margin-bottom:0px;margin-top:12pt">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="d_2019-08-08_to_2019-08-08" format="ixt:datemonthdayyearen">August&#160;8, 2019</ix:nonNumeric></p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt">
<img alt="IMAGE" src="g790557im01.jpg" /></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:24pt;margin-bottom:0pt;margin-top:0pt"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">CVS HEALTH CORPORATION</span> </p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">(Exact name of registrant as specified in its charter)</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="d_2019-08-08_to_2019-08-08" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="d_2019-08-08_to_2019-08-08">001-01011</ix:nonNumeric> </span></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="d_2019-08-08_to_2019-08-08">05-0494040</ix:nonNumeric> </span></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(State or other jurisdiction</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">of incorporation)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Commission</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">File Number)</p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(IRS Employer</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Identification No.)</p></td></tr>
<tr style="font-size:1pt;">
<td colspan="3" style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td colspan="3" style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="d_2019-08-08_to_2019-08-08">One CVS Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="d_2019-08-08_to_2019-08-08">Woonsocket</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="d_2019-08-08_to_2019-08-08" format="ixt-sec:stateprovnameen">Rhode Island</ix:nonNumeric></p></td>
<td>&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="d_2019-08-08_to_2019-08-08">02895</ix:nonNumeric></p></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td colspan="3" style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Address of principal executive offices)</p></td>
<td>&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">(Zip Code)</p></td></tr></table> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="d_2019-08-08_to_2019-08-08">(401)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="d_2019-08-08_to_2019-08-08">765-1500</ix:nonNumeric> </span></p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0px;margin-top:12pt">Former name or former address, if changed since last report: N/A</p> <div style="text-align:center"> <p style="line-height:6pt;margin-left:auto;border-bottom:1px solid #000000;width:21.05%;margin-right:auto;margin-top:12pt;margin-bottom:0px">&#160;</p></div> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="d_2019-08-08_to_2019-08-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="d_2019-08-08_to_2019-08-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12) </span></td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="d_2019-08-08_to_2019-08-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Pre-commencement communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b)) </span></td></tr></table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;vertical-align:top;white-space:nowrap;"> <span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="d_2019-08-08_to_2019-08-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span>&#32;</td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Pre-commencement communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c)) </span></td></tr></table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Securities registered pursuant to Section&#160;12(b) of the Act:</p>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:8pt;border-collapse:separate;border-spacing:0;width:100%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td style="width:34%;"></td>
<td></td>
<td style="width:33%;"></td>
<td style="width:1%;"></td>
<td style="width:33%;"></td></tr>
<tr style="page-break-inside:avoid;font-size:8pt;">
<td style="border-bottom:1pt solid #000000;white-space:nowrap;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Title of each class</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Trading</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Symbol(s)</p></td>
<td style="vertical-align:bottom;">&#160;</td>
<td style="border-bottom:1pt solid #000000;vertical-align:bottom;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">Name of each exchange</p> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:8pt;margin-bottom:0pt;margin-top:0pt">on which registered</p></td></tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:Security12bTitle" contextRef="d_2019-08-08_to_2019-08-08">Common Stock, par value $0.01 per share</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:TradingSymbol" contextRef="d_2019-08-08_to_2019-08-08">CVS</ix:nonNumeric></p></td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="d_2019-08-08_to_2019-08-08" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></p></td></tr></table> <p style="font-family:Times New Roman;margin-left:4%;text-align:left;text-indent:0%;font-size:10pt;margin-bottom:0px;margin-top:12pt">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (&#167;<span style="white-space:nowrap">240.12b-2</span> of this chapter).</p> <p style="font-family:Times New Roman;text-align:right;font-size:10pt;margin-bottom:0px;margin-top:12pt">Emerging growth company&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="d_2019-08-08_to_2019-08-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;<span style="font-family:Times New Roman;font-weight:normal">&#9744;</span></p> <p style="margin-bottom:0px;margin-top:10pt"></p> <div style="text-align:center"> <p style="line-height:0.5pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:0pt">&#160;</p></div> <div style="text-align:center"> <p style="line-height:3pt;border-bottom:0.50px solid #000000;width:100%;margin-top:0pt;margin-bottom:2pt">&#160;</p></div> <div></div> <p style="margin-top:0"></p></div>

<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto">
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;8.01.&#32;</td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Other Events.</td> </tr> </table> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:6pt">On August&#160;8, 2019, CVS Health Corporation, a Delaware corporation (the &#8220;Company&#8221; or &#8220;CVS Health&#8221;), entered into an Underwriting Agreement (the &#8220;Underwriting Agreement&#8221;) with Barclays Capital Inc., Goldman Sachs&#160;&#038; Co. LLC and J.P. Morgan Securities LLC, as representatives of the several underwriters named in Schedule I thereto (the &#8220;Underwriters&#8221;), pursuant to which the Company agreed to issue and sell to the Underwriters $1,000,000,000 aggregate principal amount of its 2.625% Senior Notes due August&#160;15, 2024 (the &#8220;2024 Notes&#8221;), $750,000,000 aggregate principal amount of its 3.000% Senior Notes due August&#160;15, 2026 (the &#8220;2026 Notes&#8221;) and $1,750,000,000 aggregate principal amount of its 3.250% Senior Notes due August&#160;15, 2029 (the &#8220;2029 Notes&#8221;, and together with the 2024 Notes and the 2026 Notes, the &#8220;Notes&#8221;). The Notes were offered pursuant to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-3ASR,</span> File No.<span style="white-space:nowrap">&#160;333-217596,</span> dated May&#160;2, 2017 (the &#8220;Registration Statement&#8221;). </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">The closing of the sale of the Notes will occur on August&#160;15, 2019, subject to the satisfaction of customary closing conditions contained in the Underwriting Agreement. The net proceeds to the Company from the sale of the Notes, after deducting the Underwriters&#8217; discounts and the estimated offering expenses payable by the Company, are approximately $3,457,890,800. A copy of the Underwriting Agreement is filed as Exhibit 1.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated by reference into the Registration Statement. </p> <p style="margin-bottom:0px;margin-top:18pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;font-weight:bold;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:10%;vertical-align:top;white-space:nowrap;">Item&#160;9.01 </td>
<td style="font-family:Times New Roman;font-weight:bold;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">Financial Statements and Exhibits.</td> </tr> </table> <p style="margin-bottom:0px;margin-top:6pt"></p>
<table cellspacing="0" cellpadding="0" border="0" style="font-family:Times New Roman;border-collapse:collapse;text-align:left;width:100%;font-size:10pt;margin-bottom:0pt;margin-top:0pt;border:0;">
<tr style="page-break-inside:avoid;">
<td style="width:4%;text-align:left;">&#160;</td>
<td style="width:4%;vertical-align:top;"> <span style="font-weight:Bold;font-style:normal">(d) </span> </td>
<td style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt;"> <span style="font-weight:Bold;font-style:normal"> <span style="font-weight:Bold;font-style:normal">Exhibits</span> </span> </td> </tr> </table>
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:92%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:auto">
<tr>
<td></td>
<td></td>
<td></td>
<td style="width:4%;"></td>
<td style="width:94%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="white-space:nowrap;vertical-align:top;padding:0;font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="white-space:nowrap;vertical-align:top;padding:0;text-align:left"> <p style="font-family:Times New Roman;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <span style="font-weight:Bold;font-style:normal">1.1 </span> </p> </td>
<td style="white-space:nowrap;vertical-align:top;padding-right:2pt;margin-bottom:0pt;margin-top:0pt;">&#160;</td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;margin-left:0.00em;text-align:left;text-indent:0.00em;font-size:10pt;margin-bottom:0pt;margin-top:0pt"> <a href="d790557dex11.htm">Underwriting Agreement dated August&#160;8, 2019, among CVS Health Corporation and Barclays Capital Inc., Goldman Sachs&#160;&#038; Co. LLC and J.P. Morgan Securities LLC, as representatives of the several underwriters named in Schedule I thereto </a> </p> </td> </tr> </table> <div></div> <p style="margin-top:0"></p>
 </div>


<p style='page-break-before:always'> </p>
<hr style="color:#999999;height:3px;width:100%" />

 <div style="font-size:10pt;width:8.5in;margin:0 auto"> <p style="font-family:Times New Roman;font-weight:bold;text-align:center;font-size:10pt;margin-bottom:0pt;margin-top:0pt">SIGNATURES </p> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0px;margin-top:12pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <div style="float:right;width:100%">
<table cellspacing="0" cellpadding="0" border="0" style="font-size:10pt;border-collapse:separate;border-spacing:0;width:40%;margin-bottom:0px;margin-top:12pt;margin-left:auto;margin-right:0px">
<tr>
<td style="width:6%;"></td>
<td style="width:2%;"></td>
<td style="width:92%;"></td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td colspan="3" style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">CVS HEALTH CORPORATION </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">By: </p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;margin-bottom:1pt;font-size:10pt;margin-top:0pt;border-bottom:1px solid #000000">/s/ Eva C. Boratto </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Eva C. Boratto </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Executive Vice President and </p> </td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Chief Financial Officer </p> </td> </tr>
<tr style="font-size:1pt;">
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td>
<td style="height:16px;">&#160;</td> </tr>
<tr style="page-break-inside:avoid;font-size:10pt;">
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt"></p> </td>
<td style="vertical-align:top;">&#160;</td>
<td style="vertical-align:top;padding:0;"> <p style="font-family:Times New Roman;text-align:left;font-size:10pt;margin-bottom:0pt;margin-top:0pt">Dated: August&#160;12, 2019 </p> </td> </tr> </table> </div> <div style="clear:both"></div> <div></div> <p style="margin-top:0"></p>
 </div>
 </body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d790557dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CVS HEALTH CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$1,000,000,000 2.625% Senior Notes due 2024 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$750,000,000 3.000% Senior Notes due 2026 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$1,750,000,000 3.250% Senior Notes due 2029 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Underwriting Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">August&nbsp;8, 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">As Representatives of the several Underwriters </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">named in <U>Schedule I</U> hereto </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Barclays
Capital Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">745 Seventh Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10019
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS Health
Corporation, a Delaware corporation (the &#147;<B>Company</B>&#148;), proposes to issue and sell $1,000,000,000 aggregate principal amount of its 2.625% Senior Notes due 2024 (the &#147;<B>2024 Notes</B>&#148;), $750,000,000 aggregate principal
amount of its 3.000% Senior Notes due 2026 (the &#147;<B>2026 Notes</B>&#148;) and $1,750,000,000 aggregate principal amount of its 3.250% Senior Notes due 2029 (the &#147;<B>2029 Notes</B>&#148; and together with the 2024 Notes and 2026 Notes, the
&#147;<B>Notes</B>&#148;) to the several underwriters named on <U>Schedule I</U> hereto (the &#147;<B>Underwriters</B>&#148;), for which Barclays Capital Inc., Goldman Sachs&nbsp;&amp; Co. LLC and J.P. Morgan Securities are acting as representatives
(the &#147;<B>Representatives</B>&#148;). The Notes will (a)&nbsp;have terms and provisions which are summarized in the Disclosure Package as of the Applicable Time and the Prospectus dated as of the date hereof (each as defined in Section&nbsp;1(a)
hereof) and (b)&nbsp;be issued pursuant to an Indenture dated as of August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;) between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust
Company, N.A.), as trustee (the &#147;<B>Trustee</B>&#148;). This agreement (this &#147;<B>Agreement</B>&#148;) is to confirm the agreement concerning the purchase of the Notes from the Company by the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&nbsp;28, 2018 (the &#147;<B>Acquisition Date</B>&#148;), the Company acquired Aetna Inc. (&#147;<B>Aetna</B>&#148;) and its
subsidiaries. Prior to the Acquisition Date, KPMG LLP (&#147;<B>KPMG</B>&#148;) were the independent public accountants with respect to Aetna. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. <I>Representations, Warranties and Agreements of the Company</I>. The Company represents and warrants to, and agrees with, each Underwriter
that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) An &#147;automatic shelf registration statement&#148; (as defined in Rule 405 under the Securities Act of 1933,
as amended (the &#147;<B>Securities Act</B>&#148;)) on Form S-3 in respect of the Notes (File No.&nbsp;333-217596) (i)&nbsp;has been prepared by the Company in conformity with the requirements of the Securities Act and the rules and regulations (the
&#147;<B>Rules and Regulations</B>&#148;) of the Securities and Exchange Commission (the &#147;<B>Commission</B>&#148;) thereunder, (ii)&nbsp;has been filed with the Commission under the Securities Act not earlier than the date that is three years
prior to the Closing Date and (iii)&nbsp;upon its filing with the Commission, automatically became and is effective under the Securities Act. Copies of such registration statement and any amendment thereto (excluding exhibits to such registration
statement but including all documents incorporated by reference in each prospectus contained therein) have been delivered by the Company to the Representatives; and no other document with respect to such registration statement or any such document
incorporated by reference therein has heretofore been filed or transmitted for filing with the Commission. For purposes of this Agreement, the following terms have the specified meanings: </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Time</B>&#148; means 5:19 p.m. (New York City time) on
the date of this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&#147;<B>Base Prospectus</B>&#148; means the base prospectus filed as part of the Registration
Statement, in the form in which it has most recently been amended on or prior to the date hereof, relating to the Notes; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&#147;<B>Disclosure Package</B>&#148; means, as of the Applicable Time, the most recent Preliminary Prospectus, together with
each Issuer Free Writing Prospectus filed or used by the Company on or before the Applicable Time and identified on <U>Schedule II(a)</U> hereto, other than a road show that is an Issuer Free Writing Prospectus under Rule 433 of the Rules and
Regulations; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&#147;<B>Effective Date</B>&#148; means any date as of which any part of the Registration Statement or any
post-effective amendment thereto relating to the Notes became, or is deemed to have become, effective under the Securities Act in accordance with the Rules and Regulations (including pursuant to Rule 430B of the Rules and Regulations); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&#147;<B>Final Term Sheet</B>&#148; means the term sheet prepared pursuant to Section&nbsp;4(a) of this Agreement and
substantially in the form attached in <U>Schedule III</U> hereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&#147;<B>Issuer Free Writing Prospectus</B>&#148; means
each &#147;free writing prospectus&#148; (as defined in Rule 405 of the Rules and Regulations) prepared by or on behalf of the Company or used or referred to by the Company in connection with the offering of the Notes, including the Final Term Sheet
and any other Issuer Free Writing Prospectus identified on <U>Schedule II</U> hereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&#147;<B>Preliminary
Prospectus</B>&#148; means any preliminary prospectus relating to the Notes, including the Base Prospectus and any preliminary prospectus supplement thereto, included in the Registration Statement or as filed with the Commission pursuant to Rule
424(b) of the Rules and Regulations and provided to the Representatives for use by the Underwriters; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&#147;<B>Prospectus</B>&#148; means the final prospectus relating to the Notes, including the Base Prospectus and the final
prospectus supplement thereto relating to the Notes, as filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations and provided to the Representatives for use by the Underwriters; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registration Statement</B>&#148; means, collectively, the various parts of the above-referenced registration
statement, each as amended as of the Effective Date for such part, including any Preliminary Prospectus and the Prospectus, all exhibits to such registration statement and all documents incorporated by reference therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any reference to &#147;<B>the most recent Preliminary Prospectus</B>&#148; will be deemed to refer to the latest Preliminary Prospectus
included in the Registration Statement or filed pursuant to Rule 424(b) of the Rules and Regulations prior to or on the date hereof (including, for purposes of this Agreement, any documents incorporated by reference therein prior to or on the date
of this Agreement). Any reference to any Preliminary Prospectus or the Prospectus will be deemed to refer to and include any documents incorporated by reference therein pursuant to Form S-3 under the Securities Act as of the date of such Preliminary
Prospectus or the Prospectus, as the case may be. Any reference to any amendment or supplement to any Preliminary Prospectus or the Prospectus will be deemed to refer to and include any document filed under the Securities Exchange Act of 1934, as
amended (the &#147;<B>Exchange Act</B>&#148;), after the date of such Preliminary Prospectus or the Prospectus, as the case may be, and incorporated by reference in such Preliminary Prospectus or the Prospectus, as the case may be; and any reference
to any amendment to the Registration Statement will be deemed to include any annual report of the Company on Form 10-K filed with the Commission pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act after the Effective Date that is
incorporated by reference in the Registration Statement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Commission has not issued any order preventing or
suspending the effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus; and no proceeding for any such purpose or pursuant to Section&nbsp;8A
of the Securities Act against the Company or related to the offering has been instituted or, to the Company&#146;s knowledge, threatened by the Commission. The Commission has not issued any order directed to any document incorporated by reference in
the most recent Preliminary Prospectus or the Prospectus, and no proceeding has been instituted </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">
or, to the Company&#146;s knowledge, threatened by the Commission with respect to any document incorporated by reference in the most recent Preliminary Prospectus or the Prospectus. The
Commission has not notified the Company of any objection to the use of the form of the Registration Statement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The
Company has been, and continues to be, a &#147;well-known seasoned issuer&#148; (as defined in Rule 405 of the Rules and Regulations) and has not been, and continues not to be, an &#147;ineligible issuer&#148; (as defined in Rule 405 of the Rules
and Regulations), in each case at all times relevant under the Securities Act in connection with the offering of the Notes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Registration Statement conformed on the Effective Date and conforms, and any amendment to the Registration Statement
filed after the date hereof will conform, in all material respects, to the requirements of the Securities Act and the Rules and Regulations. The most recent Preliminary Prospectus conforms on the date hereof, and the Prospectus, and any amendment or
supplement thereto, will conform as of its date and as of the Closing Date, in all material respects, to the requirements of the Securities Act and the Rules and Regulations. The documents of the Company incorporated by reference in the most recent
Preliminary Prospectus or the Prospectus conformed, and any further documents so incorporated will conform, when filed with the Commission, in all material respects to the requirements of the Exchange Act or the Securities Act, as applicable, and
the Rules and Regulations; and no such documents have been filed with the Commission since the close of business of the Commission on the Business Day immediately prior to the date hereof (other than those filed on the date hereof in connection with
the refinancing of the Company&#146;s indebtedness). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Registration Statement does not, as of the date hereof,
contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; <I>provided, however, </I>that no representation or warranty is made as to
information contained in or omitted from the Registration Statement in reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion
therein (which information is specified in Section&nbsp;12 hereof). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Disclosure Package did not, as of the
Applicable Time, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not
misleading; <I>provided, however,</I> that no representation or warranty is made as to information contained in or omitted from the Disclosure Package in reliance upon and in conformity with written information furnished to the Company through the
Representatives by or on behalf of any Underwriter specifically for inclusion therein (which information is specified in Section&nbsp;12 hereof). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Prospectus, and any amendment or supplement thereto, will not, as of its date and on the Closing Date, contain any
untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; <I>provided, however,</I>
that no representation or warranty is made as to information contained in or omitted from the Prospectus in reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any
Underwriter specifically for inclusion therein (which information is specified in Section&nbsp;12 hereof). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The
documents of the Company incorporated by reference in the most recent Preliminary Prospectus or the Prospectus did not, and any further documents incorporated by reference therein will not, when filed with the Commission, contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company has been duly incorporated and is an existing corporation in good standing under the laws of the State of
Delaware, with corporate power and authority to own its properties and conduct its business as described in the most recent Preliminary Prospectus and the Prospectus; and the Company is duly qualified to do business as a foreign corporation in good
standing in all other jurisdictions in which its ownership or lease of property or the conduct of its business requires such qualification, except where the failure to be so qualified or be in good standing would not, individually or in the
aggregate, have a material adverse effect on the financial condition, business, properties, results of operations or affairs of the Company and its subsidiaries taken as a whole (a &#147;<B>Material Adverse Effect</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Each subsidiary of the Company that is material to the Company and its
subsidiaries taken as a whole (collectively, the &#147;<B>Significant Subsidiaries</B>&#148;) is listed on <U>Exhibit A</U> hereto, together with its jurisdiction of organization and the beneficial ownership of the Company therein. Each Significant
Subsidiary has been duly organized and is an existing corporation or limited liability company in good standing under the laws of the jurisdiction of its organization, with corporate or limited liability company power and authority, as the case may
be, to own its properties and conduct its business as described in the most recent Preliminary Prospectus and the Prospectus; and each Significant Subsidiary of the Company is duly qualified to do business as a foreign entity in good standing in all
other jurisdictions in which its ownership or lease of property or the conduct of its business requires such qualification, except where the failure to be so qualified or be in good standing would not have a Material Adverse Effect; all of the
issued and outstanding capital stock or membership interests of each Significant Subsidiary of the Company have been duly authorized and validly issued and are fully paid and nonassessable; and the capital stock or membership interests of each
Significant Subsidiary owned by the Company, directly or through subsidiaries, are owned, except to the extent set forth in <U>Exhibit A</U> hereto, free and clear of any mortgage, pledge, lien, security interest, claim, encumbrance or defect of any
kind. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) This Agreement has been duly authorized, executed and delivered by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) The Indenture has been duly authorized by the Company and, assuming due authorization by the Trustee, when duly executed
and delivered by the Company and the Trustee, will constitute a valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent that enforceability may be limited by bankruptcy,
insolvency, reorganization, moratorium or other similar laws relating to creditors&#146; rights and remedies generally and by general principles of equity and concepts of reasonableness (regardless of whether enforcement is sought in a proceeding at
law or in equity); and the Indenture conforms in all material respects to the description thereof contained in the most recent Preliminary Prospectus and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) The Notes have been duly authorized by the Company, and when executed, authenticated and delivered and paid for as provided
in this Agreement and the Indenture, the Notes will have been duly executed, authenticated, issued and delivered and will constitute valid and legally binding obligations of the Company entitled to the benefits of the Indenture and enforceable
against the Company in accordance with their terms, except to the extent that enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to creditors&#146; rights and remedies generally and by
general principles of equity and concepts of reasonableness (regardless of whether enforcement is sought in a proceeding at law or in equity); and the Notes conform in all material respects to the description thereof contained in the Disclosure
Package and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) The execution, delivery and performance of the Indenture and this Agreement and the
issuance and sale of the Notes will not require the consent, approval, authorization or order of, or filing with, any governmental agency or body or any court (except such as have been obtained or made and such as may be required under state
securities laws). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) The execution, delivery and performance of the Indenture and this Agreement and the issuance and
sale of the Notes and compliance with the terms and provisions thereof will not conflict with or result in a breach or violation of any of the terms and provisions of, and do not and will not constitute a default (or an event that, but for the
giving of notice or the lapse of time or both, would constitute an event of default) under, or result in the creation or imposition of any lien, charge or encumbrance upon any material assets or properties of the Company or any of its subsidiaries
under (i)&nbsp;the charter, by-laws or other organizational documents of the Company or any Significant Subsidiary, (ii)&nbsp;any statute, rule, regulation, order or decree of any governmental or regulatory agency or body or any court, domestic or
foreign, having jurisdiction over the Company or any subsidiary or any of their properties, assets or operations or (iii)&nbsp;any indenture, mortgage, loan or credit agreement, note, lease, permit, license or other agreement or instrument to which
the Company or any subsidiary is a party or by which the Company or any subsidiary is bound or to which any of the properties, assets or operations of the Company or any subsidiary is subject, except, in the case of clauses (ii)&nbsp;and (iii), for
such breaches or violations which would not, individually or in the aggregate, have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) The
Company and its subsidiaries have good and marketable title to all real properties owned by them, in each case free and clear of any mortgage, pledge, lien, security interest, claim or other encumbrance or defect; the Company and its subsidiaries
hold any leased real property under valid, subsisting and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">
enforceable leases or subleases with no exceptions that would materially interfere with the use made or to be made thereof by them; neither the Company nor any of its subsidiaries is in material
default under any such lease or sublease; and no material claim of any sort has been asserted by anyone adverse to the rights of the Company or any subsidiary under any such lease or sublease or affecting or questioning the right of such entity to
the continued possession of the leased or subleased properties under any such lease or sublease, except in each case as would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) Except as described in the most recent Preliminary Prospectus and the Prospectus, the Company and its subsidiaries possess
adequate certificates, authorizations, licenses or permits issued by appropriate governmental agencies or bodies necessary to conduct the business now operated by them, except as would not, individually or in the aggregate, have a Material Adverse
Effect, and have not received any notice of proceedings relating to the revocation or modification of any such certificate, authorization, license or permit that, individually or in the aggregate, could have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) The Company and each of its subsidiaries have filed all tax returns required to be filed, which returns are complete and
correct in all material respects, and neither the Company nor any of its subsidiaries is in default in the payment of any taxes which were payable pursuant to said returns or any assessments with respect thereto, in each case except as would not,
individually or in the aggregate, have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) Neither the filing of the Registration Statement,
the most recent Preliminary Prospectus or the Prospectus nor the offer or sale of the Notes as contemplated by this Agreement gives rise to any rights, other than those which have been duly waived or satisfied, for or relating to the registration of
any securities of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) Except as described in the most recent Preliminary Prospectus and the Prospectus,
(i)&nbsp;neither the Company nor any of its Significant Subsidiaries is in violation of its charter or by-laws or other organizational documents, (ii)&nbsp;neither the Company nor any of its subsidiaries is in violation of any applicable law,
ordinance, administrative or governmental rule or regulation, or any order, decree or judgment of any court or governmental agency or body having jurisdiction over the Company or any of its subsidiaries and (iii)&nbsp;no event of default or event
that, but for the giving of notice or the lapse of time or both, would constitute an event of default, exists, or as a result of the consummation of the sale of the Notes will exist, under any indenture, mortgage, loan agreement, note, lease,
permit, license or other agreement or instrument to which the Company or any of its subsidiaries is a party or to which any of the properties, assets or operations of the Company or any such subsidiary is subject, except, in the case of clauses
(ii)&nbsp;and (iii), for such violations and defaults that would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) Except as described in the most recent Preliminary Prospectus and the Prospectus, there are no pending actions, suits or
proceedings against or, to the knowledge of the Company, affecting the Company, any of its subsidiaries or any of their respective properties, assets or operations that would have, individually or in the aggregate, a Material Adverse Effect, or
could materially and adversely affect the ability of the Company to perform its obligations under this Agreement, the Indenture or any other document governing the sale of the Notes; and no such actions, suits or proceedings are, to the knowledge of
the Company, threatened. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) The financial statements of the Company and its consolidated subsidiaries, together with the
related schedules, if any, and notes included or incorporated by reference in the most recent Preliminary Prospectus and the Prospectus, present fairly, in all material respects, the respective financial position of the Company and its consolidated
subsidiaries as of the dates shown and their results of operations and cash flows for the periods shown, and have been prepared in conformity with generally accepted accounting principles in the United States applied on a consistent basis, except as
disclosed therein. The pro forma financial information and the related notes included or incorporated by reference in the most recent Preliminary Prospectus and the Prospectus have been prepared in accordance with the applicable requirements of
Regulation S-X under the Securities Act and the assumptions underlying such pro forma financial information are reasonable and are set forth in the most recent Preliminary Prospectus and the Prospectus. The other financial and statistical
information set forth in the most recent Preliminary Prospectus and the Prospectus present fairly, in all material respects, the information shown therein and have been, except as disclosed therein, compiled on a basis consistent with that of the
financial statements included or incorporated by reference in the most recent Preliminary Prospectus and the Prospectus. The interactive data in eXtensible Business Reporting Language incorporated by reference in the most recent Preliminary
Prospectus and the Prospectus has been prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto (as of the dates such interactive data were filed) in all material respects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w) Since the date of the latest audited financial statements of the Company
included or incorporated by reference in the most recent Preliminary Prospectus and the Prospectus, there has been no material adverse change, nor any development or event involving a prospective material adverse change, in the financial condition,
business, properties or results of operations of the Company and its subsidiaries taken as a whole, other than those set forth in or contemplated by the most recent Preliminary Prospectus and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) There is no contract or document required to be described in the Registration Statement, the most recent Preliminary
Prospectus or the Prospectus or to be filed as an exhibit to the Registration Statement or to a document incorporated by reference into the Registration Statement, the most recent Preliminary Prospectus or the Prospectus which is not described or
filed as required. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y) The Company is not and, after giving effect to the offering and sale of the Notes and the
application of the proceeds thereof as described in the most recent Preliminary Prospectus and the Prospectus, will not be required to register as, an &#147;investment company&#148; as defined in the Investment Company Act of 1940, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(z) The Company and its Significant Subsidiaries maintain a system of internal accounting controls over financial reporting.
The Company&#146;s internal controls over financial reporting include those policies and procedures that pertain to the Company&#146;s ability to record, process, summarize and report a system of internal accounting controls and procedures to
provide reasonable assurance, at an appropriate cost/benefit relationship, that the unauthorized acquisition, use or disposition of assets are prevented or timely detected and that transactions are authorized, recorded and reported properly to
permit the preparation of financial statements in accordance with generally accepted accounting principles in the United States and receipts and expenditures are duly authorized. The Company&#146;s internal controls over financial reporting were
effective and provided such reasonable assurance for the preparation of financial statements as of December&nbsp;31, 2018 and, to the best of the Company&#146;s knowledge, there have been no changes in the Company&#146;s internal controls over
financial reporting subsequent to December&nbsp;31, 2018. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aa) The Company has made the evaluations of the Company&#146;s
disclosure controls and procedures required under Rule 13a-15(b) under the Exchange Act and management&#146;s conclusions regarding the effectiveness of such disclosure controls and procedures were included in the Company&#146;s annual report on
Form 10-K for the fiscal year ended December&nbsp;31, 2018. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bb) Neither the Company nor any of its subsidiaries nor, to
the Company&#146;s knowledge, any director, officer, agent, employee or affiliate of the Company or any of its subsidiaries is aware of or has taken any action (with respect to any agent or affiliate, while acting on behalf of the Company or any of
its subsidiaries), directly or indirectly, that would result in a violation by such persons of the FCPA, including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an
offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &#147;foreign official&#148; (as such term is defined in the FCPA) or
any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA, and the Company, its subsidiaries and, to the Company&#146;s knowledge, its affiliates, have conducted their businesses in
compliance in all material respects with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&#147;<B>FCPA</B>&#148; means Foreign Corrupt Practices Act of 1977, as amended, and the rules&nbsp;and regulations thereunder.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(cc) The operations of the Company and its subsidiaries are and have been conducted at all times in compliance in all
material respects with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable jurisdictions, the rules&nbsp;and
regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the &#147;Money Laundering Laws&#148;) and no action, suit or proceeding by or before any
court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the Company&#146;s knowledge, threatened. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(dd) Neither the Company nor any of its subsidiaries nor, to the
Company&#146;s knowledge, any director, officer, agent, employee or affiliate of the Company or any of its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department
(&#147;<B>OFAC</B>&#148;); and the Company will not directly or indirectly use the net proceeds from the sale of the Notes, or lend, contribute or otherwise make available such proceeds, to any subsidiary, joint venture partner or other person or
entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For
purposes of this Section&nbsp;1, as well as for Section&nbsp;6 hereof, references to &#147;<B>the most recent Preliminary Prospectus and the Prospectus</B>&#148; or &#147;<B>the Disclosure Package and the Prospectus</B>&#148; are to each of the most
recent Preliminary Prospectus or the Disclosure Package, as the case may be, and the Prospectus as separate or stand-alone documentation (and not the most recent Preliminary Prospectus or the Disclosure Package, as the case may be, and the
Prospectus taken together), so that representations, warranties, agreements, conditions and legal opinions will be made, given or measured independently in respect of each of the most recent Preliminary Prospectus or the Disclosure Package, as the
case may be, and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. <I>Purchase of the Notes by the Underwriters</I>. Subject to the terms and conditions and upon the
basis of the representations and warranties herein set forth, the Company agrees to issue and sell to the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the Company, at a price equal to 99.135% of the
principal amount of the 2024 Notes, 99.487% of the principal amount of the 2026 Notes and 98.647% of the principal amount of the 2029 Notes, in each case plus accrued interest, if any, from August&nbsp;15, 2019 to the Closing Date, the respective
principal amount of the Notes set forth opposite such Underwriter&#146;s name in <U>Schedule I</U> hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3. <I>Delivery of and Payment
for the Notes</I>. Delivery of the Notes will be made at the offices of Simpson Thacher&nbsp;&amp; Bartlett LLP, 425 Lexington Avenue, New York, NY 10017, or at such place or places as mutually may be agreed upon by the Company and the Underwriters,
at 9:00 A.M., New York City time, on August&nbsp;15, 2019 or on such later date not more than seven Business Days after such date as may be determined by the Representatives and the Company (the &#147;<B>Closing Date</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Delivery of the Notes will be made to the Representatives by or on behalf of the Company against payment of the purchase price therefor by
wire transfer of immediately available funds. Delivery of the Notes will be made through the facilities of The Depository Trust Company unless the Representatives will otherwise instruct. Delivery of the Notes at the time and place specified in this
Agreement is a further condition to the obligations of each Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4. <I>Covenants of the Company</I>. The Company covenants and
agrees with each Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company (i)&nbsp;will prepare the Prospectus in a form approved by the
Representatives and file the Prospectus pursuant to Rule 424(b) of the Rules and Regulations within the time period prescribed by such Rule; (ii)&nbsp;will not file any amendment or supplement to the Registration Statement or the Prospectus or file
any document under the Exchange Act (except for filings of annual reports on Form 10-K and quarterly reports on Form 10-Q under the Exchange Act) before the termination of the offering of the Notes by the Underwriters if such document would be
deemed to be incorporated by reference into the Prospectus, which filing is not consented to by the Representatives after reasonable notice thereof (such consent not to be unreasonably withheld or delayed); (iii)&nbsp;will advise the
Representatives, promptly after it receives notice thereof, of the time when any amendment or supplement to the Registration Statement, the most recent Preliminary Prospectus or the Prospectus has been filed and will furnish the Representatives with
copies thereof; (iv)&nbsp;will prepare the Final Term Sheet, substantially in the form of <U>Schedule III</U> hereto and approved by the Representatives and file the Final Term Sheet pursuant to Rule 433(d) of the Rules and Regulations within the
time period prescribed by such Rule; (v)&nbsp;will advise the Representatives promptly after it receives notice thereof, of the issuance by the Commission or any state or other regulatory body of any stop order or any order suspending the
effectiveness of the Registration Statement, suspending or preventing the use of any Preliminary Prospectus, the Prospectus or any Issuer Free Writing Prospectus or suspending the qualification of the Notes for offering or sale in any jurisdiction,
of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">
initiation or threatening of any proceedings for any such purpose or pursuant to Section&nbsp;8A of the Securities Act, of receipt by the Company from the Commission of any notice of objection to
the use of the Registration Statement or any post-effective amendment thereto or of any request by the Commission for the amending or supplementing of the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus or for additional
information; and (vi)&nbsp;will use its reasonable best efforts to prevent the issuance of any stop order or other such order or any such notice of objection and, if a stop order or other such order is issued or any such notice of objection is
received, to obtain as soon as possible the lifting or withdrawal thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company will furnish to each of the
Underwriters and to counsel for the Underwriters such number of conformed copies of the Registration Statement, as originally filed and each amendment thereto (excluding exhibits other than this Agreement), any Preliminary Prospectus, the Final Term
Sheet and any other Issuer Free Writing Prospectus, the Prospectus and all amendments and supplements to any of such documents (including any document filed under the Exchange Act and deemed to be incorporated by reference in the Registration
Statement, any Preliminary Prospectus or the Prospectus), in each case as soon as available and in such quantities as the Representatives may from time to time reasonably request. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) During the period in which the Prospectus relating to the Notes (or in lieu thereof, the notice referred to in Rule 173(a)
of the Rules and Regulations) is required to be delivered under the Securities Act, the Company will comply with all requirements imposed upon it by the Securities Act and by the Rules and Regulations, as from time to time in force, so far as is
necessary to permit the continuance of sales of or dealings in the Notes as contemplated by the provisions of this Agreement and by the Prospectus. If during such period any event occurs as a result of which the Prospectus as then amended or
supplemented would include an untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, or if during such period it
is necessary to amend the Registration Statement or amend or supplement the Prospectus or file any document to comply with the Securities Act, the Company will promptly notify the Representatives and will, subject to Section&nbsp;4(a) hereof, amend
the Registration Statement, or amend or supplement the Prospectus, as the case may be, or file any document (in each case, at the expense of the Company) so as to correct such statement or omission or to effect such compliance, and will furnish
without charge to each Underwriter as many written and electronic copies of any such amendment or supplement as the Representatives may from time to time reasonably request. Neither the Representatives&#146; consent to nor their delivery to offerees
or investors of, any such amendment or supplement shall constitute a waiver of any of the conditions set forth in Section&nbsp;6 of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) As soon as practicable, the Company will make generally available to its security holders and the Underwriters an earnings
statement satisfying the requirements of Section&nbsp;11(a) of the Securities Act and Rule 158 of the Rules and Regulations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company agrees, whether or not this Agreement becomes effective or is terminated or the sale of the Notes to the
Underwriters is consummated, to pay all fees, expenses, costs and charges in connection with: (i)&nbsp;the preparation, printing, filing, registration, delivery and shipping of the Registration Statement (including any exhibits thereto), any
Preliminary Prospectus, any Issuer Free Writing Prospectus, the Prospectus and any amendments or supplements thereto; (ii)&nbsp;the printing, producing, copying and delivering of this Agreement, the Indenture, closing documents (including any
compilations thereof) and any other agreements, memoranda, correspondence and other documents printed and delivered in connection with the offering, purchase, sale and delivery of the Notes; (iii)&nbsp;the services of the Company&#146;s independent
registered public accounting firm and Aetna&#146;s independent registered public accounting firm; (iv)&nbsp;the services of the Company&#146;s counsel; (v)&nbsp;the qualification of the Notes under the securities laws of the several jurisdictions as
provided in Section&nbsp;4(i) hereof; (vi)&nbsp;any rating of the Notes by rating agencies; (vii)&nbsp;the services of the Trustee and any agent of the Trustee (including the fees and disbursements of counsel for the Trustee); (viii)&nbsp;any
&#147;road show&#148; or other investor presentations relating to the offering of the Notes (including, without limitation, for meetings and travel); and (ix)&nbsp;the performance of its otherwise incident obligations hereunder for which provision
is not otherwise made in this Section&nbsp;4(e). It is understood, however, that, except as provided in this Section&nbsp;4(e) or Sections 7 and 9 hereof, the Underwriters will pay all of their own costs and expenses, including the fees and expenses
of counsel to the Underwriters and any advertising expenses incurred in connection with the offering of the Notes. If the sale of the Notes provided for herein is not consummated by reason of acts of the Company or changes in circumstances of the
Company pursuant to Section&nbsp;9 of this Agreement which prevent this Agreement from becoming effective, or by reason of any failure, refusal or inability on the part of the Company to perform any agreement on its part to be performed or because
any other condition of the Underwriters&#146; obligations hereunder is not fulfilled or if the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">
Underwriters decline to purchase the Notes for any reason permitted under this Agreement (other than by reason of a default by any of the Underwriters pursuant to Section&nbsp;8 or if the
Underwriters terminate this Agreement under Section&nbsp;9 of this Agreement upon the occurrence of any event specified in clause (iii), (iv), (vi), (vii)&nbsp;or (viii)&nbsp;of Section&nbsp;6(d)), the Company will reimburse the Underwriters for all
reasonable out-of-pocket disbursements (including fees and expenses of counsel to the Underwriters) incurred by the Underwriters in connection with any investigation or preparation made by them in respect of the marketing of the Notes or in
contemplation of the performance by them of their obligations hereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Until termination of the offering of the
Notes, the Company will timely file all reports, documents and amendments to previously filed documents required to be filed by it pursuant to Section&nbsp;12, 13(a), 13(c), 14 or 15(d) of the Exchange Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company will apply the net proceeds from the sale of the Notes as set forth in the most recent Preliminary Prospectus
and the Prospectus under the caption &#147;Use of Proceeds.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Company will pay the required Commission filing
fees relating to the Notes within the time period required by Rule 456(b)(1) of the Rules and Regulations without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) of the Rules and Regulations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company will use reasonable best efforts to arrange for the qualification of the Notes and the determination of their
eligibility for investment under the blue sky laws of such jurisdictions as the Representatives designate and will continue such qualifications in effect so long as required for the distribution of the Notes by the Underwriters, provided that the
Company will not be required to qualify as a foreign corporation or to file a general consent to service of process or subject itself to taxation in any such jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5. <I>Free Writing Prospectuses</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company represents and warrants to, and agrees with, each Underwriter that (i)&nbsp;the Company has not made, and will
not make, any offer relating to the Notes that would constitute an Issuer Free Writing Prospectus without the prior consent of the Representatives (which consent being deemed to have been given with respect to (A)&nbsp;the Final Term Sheet prepared
and filed pursuant to Section&nbsp;4(a) hereof and (B)&nbsp;any other Issuer Free Writing Prospectus identified on <U>Schedule II</U> hereto); (ii)&nbsp;each Issuer Free Writing Prospectus conformed or will conform in all material respects to the
requirements of the Securities Act and the Rules and Regulations on the date of first use, and the Company has complied with any filing requirements applicable to such Issuer Free Writing Prospectus pursuant to Rule 433 of the Rules and Regulations;
(iii)&nbsp;each Issuer Free Writing Prospectus will not, as of its issue date and through the time the Notes are delivered pursuant to Section&nbsp;3 hereof, include any information that conflicts with the information contained in the Registration
Statement, the most recent Preliminary Prospectus and the Prospectus; and (iv)&nbsp;each Issuer Free Writing Prospectus, when considered together with the information contained in the most recent Preliminary Prospectus, did not, as of the Applicable
Time, does not, as of the date hereof, and will not, as of the Closing Date, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Underwriter represents and warrants to, and
agrees with, the Company and each other Underwriter that it has not made, and will not make any offer relating to the Notes that would constitute a &#147;free writing prospectus&#148; (as defined in Rule&nbsp;405 of the Rules and Regulations)
required to be filed with the Commission, without the prior consent of the Company and the Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The
Company agrees that if at any time following issuance of an Issuer Free Writing Prospectus any event occurred or occurs as a result of which such Issuer Free Writing Prospectus would conflict with the information in the Registration Statement, the
most recent Preliminary Prospectus or the Prospectus or would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances then prevailing,
not misleading, the Company will give prompt notice thereof to the Representatives and, if requested by the Representatives, will prepare and furnish without charge to each Underwriter an Issuer Free Writing Prospectus or other document which will
correct such conflict, statement or omission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6. <I>Conditions of Underwriters&#146; Obligations</I>. The obligations of the Underwriters
hereunder are subject to the accuracy, as of the date hereof and the Closing Date (as if made at the Closing Date), of the representations and warranties of the Company contained herein, to the performance by the Company of its obligations hereunder
and to the following additional conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Prospectus shall have been filed with the Commission in a timely
fashion in accordance with Section&nbsp;4(a) hereof; all filings (including, without limitation, the Final Term Sheet) required by Rule 424(b) or Rule 433 of the Rules and Regulations shall have been made within the time periods prescribed by such
Rules, and no such filings will have been made without the consent of the Representatives (such consent not to be unreasonably withheld or delayed); no stop order suspending the effectiveness of the Registration Statement or any amendment or
supplement thereto, preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus, or suspending the qualification of the Notes for offering or sale in any jurisdiction shall have been issued;
no proceedings for the issuance of any such order shall have been initiated or threatened pursuant to Section&nbsp;8A of the Securities Act; no notice of objection of the Commission to use the Registration Statement or any post-effective amendment
thereto shall have been received by the Company; and any request of the Commission for additional information (to be included in the Registration Statement or the Prospectus or otherwise) shall have been disclosed to the Representatives and complied
with to the Representatives&#146; reasonable satisfaction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Representatives shall have received a letter, dated the
date of this Agreement, from each of Ernst&nbsp;&amp; Young LLP (&#147;<B>E&amp;Y</B>&#148;) and KPMG addressed to the Underwriters, confirming that they respectively are or were, the independent public accountants with respect to the Company and
Aetna, as the case may be, within the meaning of the Securities Act and the applicable published rules and regulations thereunder and to the effect that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(i) in each of their opinions the financial statements and schedules of the Company (in the case of E&amp;Y) and of Aetna (in
the case of KPMG), if any, examined by them and included or incorporated by reference in the most recent Preliminary Prospectus or the Prospectus, comply as to form in all material respects with the applicable accounting requirements of the
Securities Act and the Exchange Act and the related rules and regulations adopted by the Commission; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(ii) in the case of
the letter from E&amp;Y, on the basis of a reading of the latest available interim financial statements of the Company, inquiries of officials of the Company, who have responsibility for financial and accounting matters and other specified
procedures, nothing came to their attention that caused them to believe that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">at the date of the latest available balance sheet read by such accountants, and at a subsequent specified date
not more than three Business Days prior to the date of this Agreement, there was any change in the common stock, increase in long-term debt or decrease in consolidated net current assets or shareholders&#146; equity of the Company, as compared with
amounts shown on the latest balance sheet included or incorporated by reference in the most recent Preliminary Prospectus or the Prospectus; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for the period from the closing date of the latest income statement included or incorporated by reference in
the most recent Preliminary Prospectus or the Prospectus to the closing date of the latest available income statement read by such accountants and to a subsequent specified date not more than three Business Days prior to the date of this Agreement,
there were any decreases, as compared with the corresponding period in the preceding year, in consolidated net revenues or in the total or per-share amounts of consolidated income from continuing operations or of consolidated net income of the
Company, or any increases or decreases, as the case may be, in other items specified by the Representatives; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">except in all cases set forth in clauses (A)&nbsp;and (B)&nbsp;above for changes, increases or decreases which
the most recent Preliminary Prospectus or the Prospectus discloses have occurred or may occur or which are described in such letter; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(iii) in the case of the letter from E&amp;Y, on the basis of a reading of
the unaudited pro forma financial information of the Company, inquiries of officials of the Company who have responsibility for financial and accounting matters and other specified procedures, nothing came to their attention that caused them to
believe that the unaudited pro forma financial information included or incorporated by reference in the most recent Preliminary Prospectus and the Prospectus do not comply as to form in all material respects with the applicable accounting
requirements of Rule 11-02 of Regulation S-X and that the pro forma adjustments have not been properly applied to the historical amounts in the compilation of the pro forma financial information; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(iv) they have compared specified dollar amounts (or percentages derived from such dollar amounts), numerical data and other
financial information contained in the most recent Preliminary Prospectus or the Prospectus (in each case to the extent that such dollar amounts, percentages, numerical data and other financial information are derived from the general accounting
records of the Company and its subsidiaries or Aetna and its subsidiaries, as the case may be, subject to the internal controls of the Company&#146;s or Aetna&#146;s accounting system, as the case may be, or are derived directly from such records by
analysis or computation) with the results obtained from inquiries, a reading of such general accounting records and other procedures specified in such letter and have found such dollar amounts, percentages, numerical data and other financial
information to be in agreement with such results except as otherwise specified in such letter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Representatives
shall have received a letter, addressed to the Underwriters, dated the Closing Date, from each of E&amp;Y and KPMG which meet the requirements of subsection (b)&nbsp;of this Section, except that the specified date referred to in such subsection will
be a date not more than three days prior to the Closing Date for the purposes of this subsection. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Subsequent to the
execution and delivery of this Agreement, there shall not have occurred (i)&nbsp;any change, or any development involving a prospective change, in the condition (financial or other), business, properties or results of operations of the Company and
its subsidiaries, taken as a whole, which, in the judgment of the Representatives, is material and adverse and makes it impractical or inadvisable to proceed with completion of the offering or the sale of and payment for the Notes; (ii)&nbsp;any
downgrading in the rating of any debt securities of the Company by any &#147;nationally recognized statistical rating organization&#148; (as defined for purposes of Section&nbsp;3(a)(62) of the Exchange Act), or any public announcement that any such
organization has under surveillance or review its rating of any debt securities of the Company (other than an announcement with positive implications of a possible upgrading, and no implication of a possible downgrading, of such rating);
(iii)&nbsp;any change in U.S. or international financial, political or economic conditions or currency exchange rates or exchange controls as would, in the judgment of the Representatives, be likely to prejudice materially the success of the
proposed issue, sale or distribution of the Notes, whether in the primary market or in respect of dealings in the secondary market; (iv)&nbsp;any material suspension or material limitation of trading in securities generally on the New York Stock
Exchange or any setting of minimum prices for trading on such exchange; (v)&nbsp;any suspension of trading of any securities of the Company on any exchange or in the over-the-counter market; (vi)&nbsp;any banking moratorium declared by U.S. Federal
or New York authorities; (vii)&nbsp;any major disruption of settlements of securities or clearance services in the United States; or (viii)&nbsp;any attack on the United States, outbreak or escalation of major hostilities or act of terrorism
involving the United States, any declaration of war by Congress or any other substantial national or international calamity or emergency if, in the judgment of the Representatives, the effect of any such attack, outbreak, escalation, act,
declaration, calamity or emergency makes it impractical or inadvisable to proceed with completion of the offering or sale of and payment for the Notes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Representatives shall have received from Shearman&nbsp;&amp; Sterling LLP, counsel for the Company, an opinion and
10b-5 letter, addressed to the Underwriters, dated the Closing Date substantially to the effect set forth in <U>Exhibits B</U> and <U>C</U> hereto, respectively. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Representatives shall have received from Thomas S. Moffatt, Vice President, Assistant Corporate Secretary and Assistant
General Counsel of the Company, an opinion, addressed to the Underwriters, dated the Closing Date substantially in the form of <U>Exhibit D</U> hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Representatives shall have received from Simpson Thacher&nbsp;&amp; Bartlett LLP, counsel to the Underwriters, such
opinion or opinions, addressed to the Underwriters, dated the Closing Date and in form and substance satisfactory to the Representatives, with respect to the Notes, Indenture, Registration Statement, Prospectus and Disclosure Package and other
related matters as the Representatives may reasonably require, and the Company shall have furnished to such counsel such documents as they may reasonably request for the purpose of enabling them to pass upon such matters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Representatives shall have received a certificate, dated the Closing
Date, of the President or any Vice President and the principal financial or accounting officer of the Company in which such officers, to the best of their knowledge after reasonable investigation, shall state that (i)&nbsp;the representations and
warranties of the Company in this Agreement are true and correct, (ii)&nbsp;the Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date,
(iii)&nbsp;no stop order suspending the effectiveness of the Registration Statement has been issued, no proceedings for any such purpose have been initiated or threatened and (iv)&nbsp;subsequent to the dates of the most recent financial statements
in the most recent Preliminary Prospectus and the Prospectus, there has been no material adverse change, nor any development or event involving a prospective material adverse change, in the financial condition, business, properties or results of
operations of the Company and its subsidiaries, taken as a whole, other than those set forth in or contemplated by the most recent Preliminary Prospectus and the Prospectus or as described in such certificate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Representatives shall have received, on the date of this Agreement and on the Closing Date, a letter dated the date
thereof, in a form and substance reasonably satisfactory to the Representatives, from the Executive Vice President and Chief Financial Officer for the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish the Underwriters with such conformed copies of such opinions, certificates, letters and documents as the Underwriters
reasonably request. The Representatives may in their sole discretion waive on behalf of the Underwriters compliance with any conditions to the obligations of the Underwriters hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7. <I>Indemnification and Contribution</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company will indemnify and hold harmless each Underwriter, its partners, members, directors and officers and affiliates
and each person, if any, who controls such Underwriter within the meaning of Section&nbsp;15 of the Securities Act, from and against any loss, claim, damage or liability (or any action in respect thereof), joint or several, to which such Underwriter
or such person may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage or liability (or action in respect thereof) arises out of or is based upon (i)&nbsp;any untrue statement or alleged untrue statement of a
material fact contained in the Registration Statement, any Preliminary Prospectus, the Prospectus, or the Disclosure Package, each as amended or supplemented, any Issuer Free Writing Prospectus or any &#147;issuer information&#148; filed or required
to be filed pursuant to Rule&nbsp;433(d) of the Rules and Regulations or (ii)&nbsp;the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of any
Preliminary Prospectus, Issuer Free Writing Prospectus, the Prospectus and the Disclosure Package, in the light of the circumstances under which they were made) not misleading, and will reimburse each Underwriter for any legal or other expenses as
reasonably incurred by such Underwriter in connection with investigating, preparing to defend or defending against or appearing as a third-party witness in connection with any such loss, claim, damage, liability or action, notwithstanding the
possibility that payments for such expenses might later be held to be improper, in which case such payments will be promptly refunded; <I>provided</I>, <I>however</I>, that the Company will not be liable under this Section&nbsp;7(a) in any such case
to the extent that any such loss, claim, damage, liability or action arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon and in conformity with written information
furnished to the Company by any Underwriter through the Representatives specifically for use therein (which information is specified in Section&nbsp;12 hereof). The foregoing indemnity agreement shall not inure to the benefit of any Underwriter if
(i)&nbsp;such loss, claim, damage or liability (or action in respect thereof) arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in any Preliminary Prospectus, (ii)&nbsp;the Company
informed the Representatives of such untrue statement or alleged untrue statement or omission or alleged omission prior to the Applicable Time, (iii)&nbsp;such untrue statement or alleged untrue statement or omission or alleged omission was
corrected in an amended or supplemented Preliminary Prospectus (or, where permitted by law, an Issuer Free Writing Prospectus) and such corrected Preliminary Prospectus (or Issuer Free Writing Prospectus) was provided to the Underwriters such that
the Underwriters had a reasonably sufficient amount of time prior to the Applicable Time to deliver such corrected Preliminary Prospectus (or Issuer Free Writing Prospectus) to the persons to whom the Underwriters are selling the Notes,
(iv)&nbsp;the timely delivery of such corrected Preliminary Prospectus (or Issuer </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">
Free Writing Prospectus) to such person prior to the Applicable Time would have constituted a complete defense to the losses, claims, damages and liabilities asserted by such person and
(v)&nbsp;such corrected Preliminary Prospectus (or Issuer Free Writing Prospectus) was not sent or given by or on behalf of such Underwriter to such person prior to the Applicable Time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Underwriter severally, but not jointly, will indemnify and hold harmless the Company, its directors, officers and
affiliates and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Securities Act against any loss, claim, damage or liability (or any action in respect thereof) to which the Company or such person may become
subject, under the Securities Act or otherwise, insofar as such loss, claim, damage or liability (or action in respect thereof) arises out of or is based upon (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in
the Registration Statement, any Preliminary Prospectus, the Prospectus, the Disclosure Package, each as amended or supplemented, or any Issuer Free Writing Prospectus or (ii)&nbsp;the omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the statements therein (in the case of any Preliminary Prospectus, Issuer Free Writing Prospectus, the Prospectus and the Disclosure Package, in the light of the circumstances under which they were
made) not misleading, and will reimburse the Company for any legal or other expenses reasonably incurred by the Company in connection with investigating, preparing to defend or defending against or appearing as a third-party witness in connection
with any such loss, claim, damage, liability or action notwithstanding the possibility that payments for such expenses might later be held to be improper, in which case such payments will be promptly refunded; <I>provided</I>, <I>however</I>, that
such indemnification or reimbursement will be available in each such case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in reliance upon and in conformity with
written information furnished to the Company by such Underwriter through the Representatives, specifically for use therein (which information is specified in Section&nbsp;12 hereof). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Promptly after receipt by an indemnified party under this Section of notice of the commencement of any action, such
indemnified party will, if a claim in respect thereof is to be made against an indemnifying party under subsection (a)&nbsp;or (b)&nbsp;above, notify the indemnifying party of the commencement thereof; but the failure to notify the indemnifying
party shall not relieve it from any liability that it may have under subsection (a)&nbsp;or (b)&nbsp;above, except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and
provided further that the failure to notify the indemnifying party shall not relieve it from any liability that it may have to an indemnified party otherwise than under subsection (a)&nbsp;or (b)&nbsp;above. In case any such action is brought
against any indemnified party and it notifies an indemnifying party of the commencement thereof, the indemnifying party will be entitled to participate therein and, to the extent that it may wish, jointly with any other indemnifying party similarly
notified, to assume the defense thereof, with counsel satisfactory to such indemnified party (who shall not, except with the consent of the indemnified party, be counsel to the indemnifying party), and after notice from the indemnifying party to
such indemnified party of its election to assume the defense thereof, the indemnifying party will not be liable to such indemnified party under this Section for any legal or other expenses subsequently incurred by such indemnified party in
connection with the defense thereof other than reasonable costs of investigation. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened action in respect of which
any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party unless such settlement (i)&nbsp;includes an unconditional release of such indemnified party from all liability on any claims
that are the subject matter of such action and (ii)&nbsp;does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any indemnified party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If the indemnification provided for in this Section is unavailable or insufficient to hold harmless an indemnified party
under subsection (a)&nbsp;or (b)&nbsp;above, then the indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of the losses, claims, damages or liabilities referred to in subsection (a)&nbsp;or
(b)&nbsp;above (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other from the offering of the Notes or (ii)&nbsp;if the allocation provided by clause
(i)&nbsp;above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i)&nbsp;above but also the relative fault of the Company on the one hand and the Underwriters on
the other in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the
Underwriters on the other shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received by the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman">
Company bear to the total discounts and commissions received by the Underwriters from the Company under this Agreement. The relative fault shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or the Underwriters and the parties&#146; relative intent, knowledge,
access to information and opportunity to correct or prevent such untrue statement or omission. The amount paid by an indemnified party as a result of the losses, claims, damages or liabilities referred to in the first sentence of this subsection
(d)&nbsp;shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any action or claim which is the subject of this subsection (d). Notwithstanding the
provisions of this subsection (d), no Underwriter shall be required to contribute any amount in excess of the amount by which the total price at which the Notes purchased by it were resold exceeds the amount of any damages which such Underwriter has
otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. The Underwriters&#146; obligations in this subsection (d)&nbsp;to contribute are several in proportion to their respective purchase
obligations and not joint. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The obligations of the Company under this Section shall be in addition to any liability which the Company may
otherwise have and shall extend, upon the same terms and conditions, to each person, if any, who controls any Underwriter within the meaning of the Securities Act or the Exchange Act; and the obligations of the Underwriters under this Section shall
be in addition to any liability which the Underwriters may otherwise have and shall extend, upon the same terms and conditions, to each director of the Company and to each person, if any, who controls the Company within the meaning of the Securities
Act or the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8. <I>Substitution of Underwriters</I>. If any Underwriter or Underwriters default in their obligations to
purchase Notes hereunder and the aggregate principal amount of the Notes that such defaulting Underwriter or Underwriters agreed but failed to purchase does not exceed 10% of the total principal amount of the Notes, the Representatives may make
arrangements satisfactory to the Company for the purchase of such Notes by other persons, including any of the Underwriters, but if no such arrangements are made by the Closing Date, the non-defaulting Underwriters shall be obligated severally, in
proportion to their respective commitments hereunder, to purchase the Notes that such defaulting Underwriter or Underwriters agreed but failed to purchase. If any Underwriter or Underwriters so default and the aggregate principal amount of the Notes
with respect to which such default or defaults occur exceeds 10% of the total principal amount of the Notes and arrangements satisfactory to the Representatives and the Company for the purchase of such Notes by other persons are not made within 36
hours after such default, this Agreement will terminate without liability on the part of any non-defaulting Underwriter or the Company, except as provided in Section&nbsp;7. As used in this Agreement, the term &#147;Underwriter&#148; includes any
person substituted for an Underwriter under this Section. Nothing herein will relieve a defaulting Underwriter from liability for its default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9. <I>Termination</I>. Until the Closing Date, this Agreement may be terminated by the Representatives on behalf of the Underwriters by giving
notice as hereinafter provided to the Company if (i)&nbsp;the Company will have failed, refused or been unable, at or prior to the Closing Date, to perform any agreement on its part to be performed hereunder, (ii)&nbsp;any of the events described in
Sections 6(d) of this Agreement, shall have occurred, or (iii)&nbsp;any other condition to the Underwriters&#146; obligations hereunder is not fulfilled. Any termination of this Agreement pursuant to this Section&nbsp;9 will be without liability on
the part of the Company or any Underwriter, except as otherwise provided in Sections&nbsp;4(e) and 7 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any notice referred to above
may be given at the address specified in Section&nbsp;11 of this Agreement in writing or by telegraph or telephone, and if by telegraph or telephone, will be immediately confirmed in writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10. <I>Survival of Certain Provisions</I>. The agreements contained in Section&nbsp;7 of this Agreement and the representations, warranties
and agreements of the Company contained in Sections&nbsp;1 and 4 of this Agreement will survive the delivery of the Notes to the Underwriters hereunder and will remain in full force and effect, regardless of any termination or cancellation of this
Agreement or any investigation made by or on behalf of any indemnified party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11. <I>Notices</I>. Except as otherwise provided in the
Agreement, (a)&nbsp;whenever notice is required by the provisions of this Agreement to be given to the Company, such notice will be in writing by mail, telex or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
facsimile transmission addressed to the Company at One CVS Drive, Woonsocket, Rhode Island 02895, facsimile number (401)&nbsp;765-7887, Attention: General Counsel, and (b)&nbsp;whenever notice is
required by the provisions of this Agreement to be given to the several Underwriters, such notice will be in writing by mail, telex or facsimile transmission addressed to the Representatives in care of Barclays Capital Inc., 745 Seventh Ave, New
York, New York 10019, facsimile number (646)&nbsp;834-8133, Attention: Syndicate Registration, Goldman Sachs&nbsp;&amp; Co. LLC, 200 West Street, New York, New York 10282, Attention: Registration Department, and J.P. Morgan Securities LLC, 383
Madison Avenue, New York, New York 10179, facsimile number (212)&nbsp;834 6081, Attention: Investment Grade Syndicate Desk. The Company shall be entitled to act and rely upon any request, consent, notice or agreement given or made on behalf of the
Underwriters by the Representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12. <I>Information Furnished by Underwriters</I>. The Underwriters severally confirm that the names
of each of the Underwriters under the caption &#147;Underwriting&#148; in the most recent Preliminary Prospectus and the Prospectus, the concession and reallowance figures appearing in the table below the third paragraph under the caption
&#147;Underwriting&#148; in the most recent Preliminary Prospectus and the Prospectus, and the statements in the first two paragraphs of the subsection entitled &#147;Price Stabilization, Short Positions and Penalty Bids&#148; under the caption
&#147;Underwriting&#148; in the most recent Preliminary Prospectus and the Prospectus, constitute the only written information furnished to the Company by the Representatives on behalf of the Underwriters, referred to in Sections&nbsp;1(e), 1(f),
1(g), 7(a) and 7(b) of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13. <I>Nature of Relationship</I>. The Company acknowledges and agrees that in connection with the
offering and the sale of the Notes or any other services the Underwriters may be deemed to be providing hereunder, notwithstanding any preexisting relationship, advisory or otherwise, between the parties or any oral representations or assurances
previously or subsequently made by the Underwriters: (i)&nbsp;no fiduciary or agency relationship between the Company and any other person, on the one hand, and the Underwriters, on the other hand, exists; (ii)&nbsp;the Underwriters are not acting
as advisors, experts or otherwise, to the Company, including, without limitation, with respect to the determination of the public offering price of the Notes, and such relationship between the Company, on the one hand, and the Underwriters, on the
other hand, is entirely and solely a commercial relationship, based on arms-length negotiations; (iii)&nbsp;any duties and obligations that the Underwriters may have to the Company shall be limited to those duties and obligations specifically stated
herein; and (iv)&nbsp;the Underwriters and their respective affiliates may have interests that differ from those of the Company. The Company hereby waives any claims that the Company may have against the Underwriters with respect to any breach of
fiduciary duty in connection with this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14. <I>Recognition of the U.S. Special Resolution Regime</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In the event that any Underwriter is a Covered Entity and becomes subject to a proceeding under a U.S. Special Resolution
Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this
Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event that any Underwriter is a Covered Entity and it or a BHC Act Affiliate of such Underwriter becomes subject to
a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S.
Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As used in
this Section&nbsp;14: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&#147;<B>BHC Act Affiliate</B>&#148; has the meaning assigned to the term
&#147;<B>affiliate</B>&#148; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&#147;<B>Covered
Entity</B>&#148; means any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
252.82(b); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
47.3(b); or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
382.2(b). </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&#147;<B>Default Right</B>&#148; has the meaning assigned to that term in, and shall be
interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">&#147;<B>U.S. Special
Resolution Regime</B>&#148; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated
thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15. <I>Parties</I>. This Agreement will inure to the benefit of and be binding upon the several Underwriters, the Company and
their respective successors. This Agreement and the terms and provisions hereof are for the sole benefit of only those persons, except as specifically provided in Section&nbsp;7 of this Agreement. Nothing in this Agreement will be construed to give
any person, other than the persons referred to in this paragraph, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">16. <I>Definition of &#147;Business Day&#148;</I>. For purposes of this Agreement, the term &#147;<B>Business Day</B>&#148; means any day on
which the New York Stock Exchange is open for trading, other than any day on which commercial banks are authorized or required to be closed in New York City. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">17. <I>Governing Law</I>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">18. <I>Headings</I>. The headings herein are inserted for convenience of reference only and are not intended to be part of, or to affect the
meaning or interpretation of, this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">19. <I>Counterparts</I>. This Agreement may be signed in one or more counterparts, each of
which will constitute an original and all of which together will constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by facsimile or other electronic transmission (i.e., a &#147;pdf&#148;
or &#147;tif&#148;) shall be effective as delivery of a manually executed counterpart thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please confirm, by signing and returning to us one or more counterparts of this Agreement,
that the foregoing correctly sets forth the Agreement between the Company and the several Underwriters. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="35%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32" COLSPAN="3"></TD>
<TD HEIGHT="32" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CVS H<SMALL>EALTH</SMALL> C<SMALL>ORPORATION</SMALL></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Carol A. DeNale</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Carol A. DeNale</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:&nbsp;Senior&nbsp;Vice&nbsp;President&nbsp;and&nbsp;Treasurer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to Underwriting
Agreement </I></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="35%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="28%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Confirmed and accepted as of the date first above mentioned</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32" COLSPAN="3"></TD>
<TD HEIGHT="32" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BARCLAYS CAPITAL INC.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="49"></TD>
<TD HEIGHT="49" COLSPAN="2"></TD>
<TD HEIGHT="49" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Barbara Mariniello</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Barbara Mariniello</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32" COLSPAN="3"></TD>
<TD HEIGHT="32" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">GOLDMAN SACHS&nbsp;&amp; CO. LLC</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="49"></TD>
<TD HEIGHT="49" COLSPAN="2"></TD>
<TD HEIGHT="49" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Adam Greene</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Adam Greene</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Managing Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32" COLSPAN="3"></TD>
<TD HEIGHT="32" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. MORGAN SECURITIES LLC</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="49"></TD>
<TD HEIGHT="49" COLSPAN="2"></TD>
<TD HEIGHT="49" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Som Bhattacharyya</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Som Bhattacharyya</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Executive Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="32" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">As Representatives and on behalf of the several Underwriters named in <U>Schedule I</U> hereto</TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page to Underwriting
Agreement </I></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE I </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal Amount<BR>of&nbsp;the 2024 Notes to<BR>be purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal Amount<BR>of&nbsp;the 2026 Notes to<BR>be purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal Amount<BR>of&nbsp;the 2029 Notes to<BR>be purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">120,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">90,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">210,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">120,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">90,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">210,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">120,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">90,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">210,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">100,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">175,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">100,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">175,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">45,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">33,750,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">78,750,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">45,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">33,750,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">78,750,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MUFG Securities Americas Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">45,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">33,750,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">78,750,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">45,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">33,750,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">78,750,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SunTrust Robinson Humphrey, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">45,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">33,750,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">78,750,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Bancorp Investments, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">45,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">33,750,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">78,750,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Credit Suisse Securities (USA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">35,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fifth Third Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">35,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC Capital Markets LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">35,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Santander Investment Securities Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">35,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SMBC Nikko Securities America, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">35,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNY Mellon Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,500,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,375,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,875,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ICBC Standard Bank Plc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,500,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,375,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,875,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBanc Capital Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,500,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,375,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,875,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loop Capital Markets LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,500,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,375,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,875,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TD Securities (USA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,500,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,375,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,875,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CL King&nbsp;&amp; Associates, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,500,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,625,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,125,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">750,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,750,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ISSUER FREE WRITING PROSPECTUSES </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Final Term Sheet, dated August&nbsp;8, 2019, relating to the Notes, as filed pursuant to Rule 433 under the
Securities Act and attached as <U>Schedule III</U> hereto. </P></TD></TR></TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRICING TERM SHEET </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Filed pursuant to Rule 433 </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Free Writing Prospectus dated August&nbsp;8, 2019 </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Registration Statement No.: 333-217596 </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CVS HEALTH CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Pricing Term Sheet&#151;August 8, 2019 </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>$1,000,000,000 2.625% Senior Notes due 2024 </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>$750,000,000 3.000% Senior Notes due 2026 </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>$1,750,000,000 3.250% Senior Notes due 2029 </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Issuer:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CVS Health Corporation (the &#147;<B>Issuer</B>&#148;)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Description of Securities:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">$1,000,000,000 2.625% Senior Notes due 2024 (&#147;<B>2024 Notes</B>&#148;)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">$750,000,000 3.000% Senior Notes due 2026 (&#147;<B>2026 Notes</B>&#148;)</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">$1,750,000,000 3.250% Senior Notes due 2029 (&#147;<B>2029 Notes</B>&#148; and, together with the 2024 Notes and the 2026 Notes, the
&#147;<B>Notes</B>&#148;)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Maturity Dates:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August 15, 2024 for the 2024 Notes</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August 15,
2026 for the 2026 Notes</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">August 15, 2029 for the 2029 Notes</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Settlement Date:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">August 15, 2019 (T+5)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Extended Settlement:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">It is expected that delivery of the Notes will be made, against payment of the Notes, on or about August 15, 2019, which will be the fifth business day in the United States following the date of pricing of the Notes. Under Rule
15c6-1 under the Securities Exchange Act of 1934, as amended, purchases or sales of securities in the secondary market generally are required to settle within two business days (T+2), unless the parties to any such transaction expressly agree
otherwise. Accordingly, purchasers of the Notes who wish to trade the Notes on the date of the Prospectus Supplement dated August 8, 2018, or on the next two succeeding business days will be required, because the Notes initially will settle within
five business days (T+5) in the United States, to specify an alternate settlement cycle at the time of any such trade to prevent a failed settlement. Purchasers of the Notes who wish to trade the Notes prior to August 15, 2019 should consult their
advisors.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Issue Prices:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">99.485% of principal amount for the 2024 Notes</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">99.887% of principal amount for the 2026 Notes</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">99.097% of
principal amount for the 2029 Notes</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Coupons:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.625% for the 2024 Notes</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.000% for the 2026
Notes</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">3.250% for the 2029 Notes</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Benchmark Treasury:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2024 Notes: 1.750% UST due July 31, 2024</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2026
Notes: 1.875% UST due July 31, 2026</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2029 Notes: 2.375% UST due May 15, 2029</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Benchmark Treasury Price and Yield:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2024 Notes: 101-00<SUP STYLE="vertical-align:top">3</SUP>&#8260;<SUB STYLE="vertical-align:bottom">4</SUB>; 1.536%</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2026 Notes: 101-22; 1.618%</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2029 Notes: 105-31+;
1.707%</P></TD></TR></TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Spread to Benchmark Treasury:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2024 Notes: +120 basis points (1.20%)</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2026
Notes: +140 basis points (1.40%)</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2029 Notes: +165 basis points (1.65%)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Yield to Maturity:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2024 Notes: 2.736%</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2026 Notes: 3.018%</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2029 Notes: 3.357%</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Interest Payment Dates:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Semiannually on February 15 and August 15, commencing on February 15, 2020.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Record Dates:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">February 1 and August 1</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Optional Redemption Provisions:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>2024 Notes</U>: Prior to July 15, 2024 (one month prior to the maturity date), make-whole call at any time at the greater of 100% or
discounted present value at Treasury Yield plus 20. On or after July 15, 2024, redeemable at a redemption price equal to 100% of the aggregate principal amount of the 2024 Notes being redeemed.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>2026 Notes</U>: Prior to June 15, 2026 (two months prior to the maturity date),
make-whole call at any time at the greater of 100% or discounted present value at Treasury Yield plus 25. On or after June 15, 2026, redeemable at a redemption price equal to 100% of the aggregate principal amount of the 2026 Notes being
redeemed.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>2029 Notes</U>: Prior to May 15, 2029 (three months prior to the
maturity date), make-whole call at any time at the greater of 100% or discounted present value at Treasury Yield plus 25. On or after May 15, 2029, redeemable at a redemption price equal to 100% of the aggregate principal amount of the 2029 Notes
being redeemed.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Change of Control:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Upon certain change of control events, the Issuer will be required to make an offer to purchase the Notes in cash at a price equal to 101% of their aggregate principal amount.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Joint Book-Running Managers:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">B<SMALL>ARCLAYS</SMALL> C<SMALL>APITAL</SMALL> I<SMALL>NC</SMALL>.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">G<SMALL>OLDMAN</SMALL> S<SMALL>ACHS</SMALL> &amp; C<SMALL>O</SMALL>. LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P M<SMALL>ORGAN</SMALL> S<SMALL>ECURITIES</SMALL> LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">B<SMALL>OF</SMALL>A S<SMALL>ECURITIES</SMALL>, I<SMALL>NC</SMALL>.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">W<SMALL>ELLS</SMALL> F<SMALL>ARGO</SMALL> S<SMALL>ECURITIES</SMALL>, LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Co-Managers:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">C<SMALL>ITIGROUP</SMALL> G<SMALL>LOBAL</SMALL> M<SMALL>ARKETS</SMALL> I<SMALL>NC</SMALL>.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">M<SMALL>IZUHO</SMALL> S<SMALL>ECURITIES</SMALL> USA LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MUFG
S<SMALL>ECURITIES</SMALL> A<SMALL>MERICAS</SMALL> I<SMALL>NC</SMALL>.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RBC C<SMALL>APITAL</SMALL> M<SMALL>ARKETS</SMALL>, LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">S<SMALL>UN</SMALL>T<SMALL>RUST</SMALL> R<SMALL>OBINSON</SMALL> H<SMALL>UMPHREY</SMALL>, I<SMALL>NC</SMALL>.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. B<SMALL>ANCORP</SMALL> I<SMALL>NVESTMENTS</SMALL>, I<SMALL>NC</SMALL>.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">C<SMALL>REDIT</SMALL> S<SMALL>UISSE</SMALL> S<SMALL>ECURITIES</SMALL> (USA) LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">F<SMALL>IFTH</SMALL> T<SMALL>HIRD</SMALL> S<SMALL>ECURITIES</SMALL>, I<SMALL>NC</SMALL>.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PNC C<SMALL>APITAL</SMALL> M<SMALL>ARKETS</SMALL> LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">S<SMALL>ANTANDER</SMALL> I<SMALL>NVESTMENT</SMALL> S<SMALL>ECURITIES</SMALL> I<SMALL>NC</SMALL>.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SMBC N<SMALL>IKKO</SMALL> S<SMALL>ECURITIES</SMALL> A<SMALL>MERICA</SMALL>, I<SMALL>NC</SMALL>.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BNY M<SMALL>ELLON</SMALL> C<SMALL>APITAL</SMALL> M<SMALL>ARKETS</SMALL>, LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ICBC S<SMALL>TANDARD</SMALL> B<SMALL>ANK</SMALL> P<SMALL>LC</SMALL><SUP STYLE="font-size:85%; vertical-align:top">1</SUP></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">K<SMALL>EY</SMALL>B<SMALL>ANC</SMALL> C<SMALL>APITAL</SMALL> M<SMALL>ARKETS</SMALL> I<SMALL>NC</SMALL>.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">L<SMALL>OOP</SMALL> C<SMALL>APITAL</SMALL> M<SMALL>ARKETS</SMALL> LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TD S<SMALL>ECURITIES</SMALL> (USA) LLC</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">CL K<SMALL>ING</SMALL>
&amp; A<SMALL>SSOCIATES</SMALL>, I<SMALL>NC</SMALL>.</P></TD></TR></TABLE>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>CUSIP Numbers:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2024 Notes: 126650 DE7</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2026 Notes: 126650
DF4</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2029 Notes: 126650 DG2</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ICBC Standard Bank Plc is restricted in its U.S. securities dealings under the United States Bank Holding
Company Act and may not underwrite, subscribe, agree to purchase or procure purchasers to purchase Notes that are offered or sold in the United States. Accordingly, ICBC Standard Bank Plc shall not be obligated to, and shall not, underwrite,
subscribe, agree to purchase or procure purchasers to purchase Notes that may be offered or sold by other underwriters in the United States. ICBC Standard Bank Plc shall offer and sell Notes constituting part of its allotment solely outside the
United States. </P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Changes to Preliminary Prospectus Supplement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Relationships </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following paragraph shall
replace the first paragraph under the heading &#147;Underwriting&#151;Other Relationships&#148; in the Preliminary Prospectus Supplement: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From time to time, certain of the underwriters and/or their respective affiliates have directly and indirectly engaged, and may engage in the
future, in investment and/or commercial banking with us for which they have received, or may receive, customary compensation, fees and expense reimbursement. Barclays Capital Inc. and Goldman Sachs&nbsp;&amp; Co. LLC will act as dealer managers for
the Tender Offers. To the extent any of the underwriters or their affiliates own notes that are the subject of the Tender Offers they may tender such notes pursuant to the terms of the Tender Offers. A member of our board of directors is an officer
of Bank of America Corporation, an affiliate of one of the underwriters. An affiliate of one of the underwriters, BNY Mellon Capital Markets, LLC, is acting as Trustee, Registrar and Paying Agent in the offering. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Issuer has filed a registration statement (including a prospectus and preliminary prospectus supplement) with the SEC for the offering to which this
communication relates. Before you invest, you should read the prospectus and preliminary prospectus supplement in that registration statement, and other documents the Issuer has filed with the SEC for more complete information about the Issuer and
this offering. You may get these documents for free by visiting EDGAR on the SEC website at </B><B><I><U>www.sec.gov</U></I></B><B>. Alternatively, you may obtain a copy of the prospectus and the preliminary prospectus supplement from Barclays
Capital Inc. by calling toll-free 1-888-603-5847, Goldman Sachs&nbsp;&amp; Co. LLC by calling toll-free 1-866-471-2526 or J.P. Morgan Securities LLC by calling collect 1-212-834-4533. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER
NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM. </B></P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SIGNIFICANT SUBSIDIARIES </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used
in the Underwriting Agreement, the &#147;Significant Subsidiaries&#148; of the Company are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="22%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Name</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center">&nbsp;&nbsp;Jurisdiction&nbsp;of&nbsp;Organization&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;%&nbsp;Owned&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Liens/Encumbrances&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Aetna Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Pennsylvania</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;None</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CVS Pharmacy, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Rhode Island</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;None</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Caremark, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">California</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;None</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CaremarkPCS Health, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Delaware</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;None</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Caremark Rx, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Delaware</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;None</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CVS Caremark Part D Services,
L.L.C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Delaware</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;None</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Omnicare, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Delaware</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;None</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SilverScript Insurance Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Tennessee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;None</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cvs-20190808.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.3 - Release 2019.1 -->
<!-- Creation date: 8/12/2019 10:53:38 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:cvs="http://www.cvshealth.com/20190808"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.cvshealth.com/20190808"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20190808_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20190808_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cvs-20190808_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.3 - Release 2019.1 -->
<!-- Creation date: 8/12/2019 10:53:38 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cvs-20190808_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Addin 62.6.3 - Release 2019.1 -->
<!-- Creation date: 8/12/2019 10:53:38 PM Eastern Time -->
<!-- Copyright (c) 2019 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cvs-20190808.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g790557im01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g790557im01.jpg
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M="!E;F0](G(B/S[_[0!(4&AO=&]S:&]P(#,N,  X0DE-! 0       \< 5H
M QLE1QP"   "  ( .$))300E       0_.$?B<BWR7@O-&(T!UAWZ__N  Y!
M9&]B90!DP     '_VP"$  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$" @(" @(" @(" @,# P,# P,# P,! 0$! 0$! @$!
M @(" 0(" P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# __  !$( !$ :@,!$0 "$0$#$0'_Q "I   !! (#
M       ( 0('"0,$!08* 0$   <! 0               0(#! 8'" 4)$
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M2YO4VKE^QF)[-\2ZNI*'L66TA8$%2[.3V#$6F$]T3!D#$W+8XL,2OR)K8B9
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D%X<^]TA&07HQX@>^'I"%_'GU8^7/2$-_>8\&?>QTA#^D(__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d790557d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20190808.xsd" xlink:type="simple"/>
    <context id="d_2019-08-08_to_2019-08-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2019-08-08</startDate>
            <endDate>2019-08-08</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="d_2019-08-08_to_2019-08-08"
      id="Hidden_dei_EntityRegistrantName">CVS HEALTH Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="d_2019-08-08_to_2019-08-08">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="d_2019-08-08_to_2019-08-08"
      id="Hidden_dei_EntityCentralIndexKey">0000064803</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d_2019-08-08_to_2019-08-08">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d_2019-08-08_to_2019-08-08">2019-08-08</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="d_2019-08-08_to_2019-08-08">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d_2019-08-08_to_2019-08-08">001-01011</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d_2019-08-08_to_2019-08-08">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d_2019-08-08_to_2019-08-08">One CVS Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d_2019-08-08_to_2019-08-08">Woonsocket</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d_2019-08-08_to_2019-08-08">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d_2019-08-08_to_2019-08-08">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d_2019-08-08_to_2019-08-08">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d_2019-08-08_to_2019-08-08">765-1500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="d_2019-08-08_to_2019-08-08">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d_2019-08-08_to_2019-08-08">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d_2019-08-08_to_2019-08-08">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d_2019-08-08_to_2019-08-08">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="d_2019-08-08_to_2019-08-08">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d_2019-08-08_to_2019-08-08">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d_2019-08-08_to_2019-08-08">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="d_2019-08-08_to_2019-08-08">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.2</span><table class="report" border="0" cellspacing="2" id="idp6627198208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 08, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  08,  2019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MNO[PNPJ[8.S._F/CBZ!LX-==R"]02P,$%     @ P8(,3YE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M+TWRL&6=-XJ<[O9GJ,6@WLX%][]$\0-02P,$%     @ P8(,3Q9M(W]# 0
M/ (   \   !X;"]W;W)K8F]O:RYX;6R-4<MNPC 0_!7+'] $U"(5$2ZE#Z2J
M1:7B[B0;LL*/R-Y R]=W[2B%WGJR=W8\.SM>G)P_E,X=Q)?1-A2R)>KF61:J
M%HP*-ZX#RYW&>:.(2[_/0N=!U:$%(*.S:9[/,J/0RN5BU-KX[+IP!!6ALPQ&
M8(=P"I=^+(5BPA$^55G(7 K5DWM"3>!7BN#9N[Y#NR_D1(H&?:!MG)V8!BT:
M/$.=JM"ZTXOS>':6E-Y6WFF=7L5&>L03PB^R T]8_2&2*C\4>RWD+&?!(P8L
M42-]%S+=-4C>(KM:(^4PGD.(<_^?&%W38 4K5_4&+ TY>M!QN@TM=D$*JPP4
M<J0(96OQ:(G=B+4=I)@;=^'1ZWK8BSBQBUGAY\@-OZXGR?CHMH8&+=1O/" P
MSB%4&R_BD72FMW>3>PZ[U_J!L7?[ZE32CQKCQRU_ %!+ P04    " #!@@Q/
M_\ F"+T   "% @  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSK9)!
M"H,P$ "_(GE 5VWIH:BG7KRV_4#0U8B:A.R6ZN^;>E%!H0<O"6'#S$"2/+"3
MW!A-JK$4#'VG*16*V=X J%#82SH9B]I/*N-ZR?[H:K"R:&6-$(?A%=R2(;)D
MR0SR,A4N+R,1O*2KD5,!0P<?XUI2B$PP;=')"_R5T>(_>E-538%W4[Q[U+Q1
M,0L$; ?%<Q IZ;!\LFMT34>'K.![,>=%#(\='E\Q4??TEUG/7H(PK8>_R43]
M-<#JUV5?4$L#!!0    ( ,&"#$\+C]@#(0$  %<$   3    6T-O;G1E;G1?
M5'EP97-=+GAM;+5434_#, S]*U.O:,W@P %MNP!7F 1_("1N&S5?LKW1_7O<
M;D-B*F)HVR6)\^SW7A(K\_=M!IITP4=:% US?E"*3 -!4YDR1$&JA$&SA%BK
MK$VK:U!WL]F],BDR1)YRSU$LYT]0Z;7GR>-NOZ=>%#IG[XQFEZ+:1'M$.MT3
ME@A^R*'&9;J1A&+RW D+R=ZB$)0*=8+"<6$?2]WK!A"=A7]92U7E#-ADUD%*
M2LH(VE(#P,&7U&@$^\;H8KWWN]+(+SH(L>J\^I%07L\';SV,&QB02RJSM 6,
M20W ;KP]2_#0#28A3#,*BNQ&CB>65H*2ZA,O>43H6\>"/4E<J*_WL)\)VV$]
M=N'?(*EA.N_6_VATF<N@7?S-R$=*[4%?#?_)\@M02P$"% ,4    " #!@@Q/
M'R// \     3 @  "P              @ $     7W)E;',O+G)E;'-02P$"
M% ,4    " #!@@Q/)^B'#H(   "Q    $               @ 'I    9&]C
M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,&"#$_<;(RU[P   "L"   1
M          "  9D!  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( ,&"
M#$^97)PC$ 8  )PG   3              "  ;<"  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ P8(,3PNJG*V: @  DPL  !@
M ( !^ @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( ,&"
M#$^6U;VV1P(  .L%   4              "  <@+  !X;"]S:&%R9613=')I
M;F=S+GAM;%!+ 0(4 Q0    ( ,&"#$^ZH3F*UP$  #(&   -
M  "  4$.  !X;"]S='EL97,N>&UL4$L! A0#%     @ P8(,3Q9M(W]# 0
M/ (   \              ( !0Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( ,&"#$__P"8(O0   (4"   :              "  ;,1  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,&"#$\+C]@#(0$  %<$
M   3              "  :@2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   *  H @ (  /H3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>97</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d790557d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d790557d8k.htm">d790557d8k.htm</File>
    <File>cvs-20190808.xsd</File>
    <File>cvs-20190808_lab.xml</File>
    <File>cvs-20190808_pre.xml</File>
    <File>d790557dex11.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g790557im01.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d790557d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d790557d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20190808_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20190808_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cvs-20190808.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 97,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cvs",
   "nsuri": "http://www.cvshealth.com/20190808",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d790557d8k.htm",
      "contextRef": "d_2019-08-08_to_2019-08-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d790557d8k.htm",
      "contextRef": "d_2019-08-08_to_2019-08-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.cvshealth.com//20190808/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-19-219029-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-19-219029-xbrl.zip
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M82.^78/K<T1S:QS72<_ES7'R6PY3HYKY0""T"';#)?0#A:.^@ZEGZCA8 (_
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MV[=F:#4X/BWI__#H5/]W2*W_ %!+ P04    " #!@@Q/!<E?%A=I  !OB (
M$    &0W.3 U-3=D97@Q,2YH=&WM?6=SVUB6Z'=6\3_<\F[/DVHAM:AD.;2K
MJ&!;,[*E)\K3V^\;2((BQB#  4#)FE__3K@1@4&BDJVMG;9((MQ[[LGQ_>>+
M+R<?WG\^:A]^:#;>7QQ?G!Q]./K?M=9ZZ_WO_ F^_EW^+M[OGQ[^)?8_'9R>
MG)[_\>K/S\<71Z_P!]%LP'4'09P'Z8?WA\?_%)V+OTZ._GAU'?;SX=N]]9TP
M?B7\*+R,_W@5!8.<[GI_IBX;^>EE&*_ER?CMQCA_)^3G;I+GR8B_&B1QOI:%
M_PG>MLSG@3\*HYNW%^$HR,37X%J<)R,?WM0^.?[T]8]7:7@YA%>]W_]P]&,8
M=L-<P,;$^]_W/[S__0QW5K6 UN825] CD- 2#O[9$0#(DXO/XN#T_.STO'UQ
M?/KUL5;SWRUO8V-#_4]LKN]N[OPF.D$<)JGXFN1P?W\2B,V-S>U92USFB=DK
M?+UCUK>U#O^M7M_N8ZVOY;DKW-RI6>&;QSKD]]\^?(O[07J=AGD87XKV91H$
M(_@=%O3MPT,N2E)B>W(YR?*_Q=UL_&[/ ]BT$#9G'ZI9P5)6\&'?3WN1?Y.)
M W\<YGXDCN/>NKAG?/GP*8GZ\(?H^+UAQAO^FS\:OQ,'R;HX.3F8LNVEO/_O
MZV?KXDN27N(:@MX$,0"N4&^NV?INS:OE5\BYWV[^MN!2VIDX#\9ID 'B^7EX
M!;\F Y$/ Y$%5T$*)Z*1-$BSVYS,G987^Z.@+\)8 +5T>L.@/XD"<8P$(H9!
M&N3)E*.J@]=""^C]G@B%I,U&"4OO$4E>;^\ <ES!N0Q%&_X!=G7/;\0__TK2
M[YY0?XG6!G !U#+N%<@G?A_QWX_[XA/L-T(V^/86)YL'/_*U$/ USM]N+XIJ
MI ($?I0/X9R3=)RD0 ])[ E?' :1?^VG@>B9[\4*$LG?_JNU_?H=*A#):.S'
M-\BV\;N]=ZN>&*?).,G@+8"F89;! >(.LR"*1$'"^Y? _"_]/(![PK@7C@''
M_%$R 6$ U!CFV70=P%T*?457.*MQ1';%"YL-]XU3I7KIC;NE-])F"W)X]CZG
M2NK26]\4WTHOS9/+ *Y,Q74(M(/W&)#0!6:]'O[<;.AGEC8!1V<SPXG-#)DY
M)5.8D[M@FY,Z1S. K5X/P]Y05,I#3\P46+BK&JF">.OW2,7P,Y&ZS+[9<)=8
MD 76*M?%!5S(,+P. 857_%5>R="_"H#TTA$#%[#^*LR 0C*Y)UQ -AD!O0(E
M$C/'5QZ&62]*L@G\>.;WOON7 2Y/RI[V>!R%/;\+\$0ZY5.%[\_2)!L'O7P"
M2 %8U+=NP<\$=OB\$OCX7K@H&(0QOQ,@@F3+2V[!XIL-OIH1=:4K=],-F%9A
M(Y,TF_B FG"0 -)CXBNX7OO5MM+4VD&M::-('?I&&Z^Z07X=! P*R3MH'0CD
M?3_^CL_67/@+L Q LXL47J6N!B:]WEX7*X [HR"-;L3W.+F.<565CZ![D;%9
M-P/FP>4Y_A($A45?\+<%! CAB+6:"C? 9WV'UE_M;8;$_'I)/ C3$6W6W _?
M]H(T1L3$'P#<O:&?!>I &=4&:3)R@-2]H8\V+4U5&&OUU#L)B],8UG<5C+I!
MRF>_R1KS7@&,[=Z_)T ,)# . 6T<LG?.'B], :W:01[[K&"LF,?@ET7>"NRR
MV<@FW2SLAT!; <#A+$6N*7E6\=V>^,?9ET_ +LZL)^-7]H.O@2;H;H3,."#P
MP-%T@1QAC3UDU4 2&;-68!5(C?A"6N'=#^+-H@?1@G<>.VP+&(\G_O33%-:I
MM J-FYI=:'E]_($YFSH(S2#YSFM^$**Q1U\0_O+^/4%\QD+%9B,?^OEM5)>B
MEGPGH !W$^U88J$_@9< 7'HB&P;1 #9X&6:Y5&(R@!@!1HK/%9=IGJ-$V][8
M8;E'@+,D2[M'8KOU9FO+ ^T! #9"A.D7:,"]PT*V592='X%_B<[:%KY.X9/#
M 58^AA'^O<Z$MK6UM;;9>KWS9G=5K(1:!&7 48&=PMF-?20CR2;4J<+#D0G!
MN\+\QN@%:4!4YV!&88-*]*0 "D8) . D8D2CG5KJP[F^Z-Q<9)-7^1UX\=$/
MX'SQ)2UW!-*G4KV4/SC*"4HP.AH/8%$"Q@  US>;M1Y>>YQQD@-2IU%(/_NQ
M$:V(V,3.AX#_X@8N NXSMOG- 8AS9.;(:UBFAGI-DS&\%?4[6!->4[$H("^%
MJ7X$\JP;]'PI^N&UP6"  APTC;JUK\.SQB';K]FD-ZQ!="9BY+B(K/1-KK2U
MX$<OFO1Q?0&[)$EZE1X&7%<_K3L!J,3J-EBXZ">]"2,4?"_M!4;(-!C BT#H
M(3H2ZQ@;?0;0,_>)[F@Y8;PJ2+&BD^P'$6R] J\EZ MJ&ZO!<2(24H/5BDI,
M>QJ8X%SQ!72)>D"S4;\EN6J!V,?P!&H+;$1$3 %>F@$)XMVH]-9CPSHR!M0)
MV((BN@$TT(R<I><@ <7HFC0(TC]9%45]';88#D)XS2CP4<7(WBK9]/OA\3\_
MO/]=^L.;#4'__WXL.OE-%/SQ?\:@BJYUT\#_OM8-< ]O_>@:5/+_@S=_/A>=
MX_\'+'WK%< *KW]%_O:W__6&_N^5^//X\.+S'Z_ </Y-.]@.CKY>')T_E#/>
M%B7;!5&RLZ@H,2J(JY);)A=".!,[;UMOQ'A]!&J+5CH/D-GF<#5R>I2-DI>4
M3O/='27F\K:YCQJH,3-*V\0]=/$:BW09O0'O0?1HX77N,(R.HBM/V3\HB_!O
MMI'"G AGE(""GP;H)28."+2C9"H0)Q*$S7 MD\>#NU#<("4D1GB^NZL_<7F
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M^^J*0S#MPA% . 0 1#>U@7BQ8@5X\R&^2,:7RVZ7,O_CK:?(A_VX9_' @EZ
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MP#VVV2T2]OL@O3(5.%/275K"/GDJ^B&O5>W(LW  ,^"S2<2\$+^4J0\8SQK
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M9D%R$ZCD.Q! EJDW9\CNFFK!L2D%H:HT4%"*<Q!VI:HY.KW?>2LET" ;D@F
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M9VSEW&.6/17$*YO/LF<A*@)ZZ)NP9[[-6U)N0G4A7VLE-L@X'+= (,6%NPV
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M<UL"?B=">=K2*/.W3[8K^J*D"%'+T<XNEE:BM?&;>I\6??6K\:K"D(2DF)X
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M[CC$0SS*\LDX78Y,D@F%R+R9_2J(^W#3"S:_]-ZG-<>PV*+3>53MGJQYM\T
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MO35:3"7KV]Q> L>M;C7(,3<"\%D:1.$HC'U*@Z^JT;3;#M:HK$OI]T5)+72
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M.W-83X&7($\*,PNG_X+=(8.X#.A2X(]F ?CX 6I]H*5ABBH1S]'AI_:Y:O6
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M7^8;\O/+@*[NO[])^%W'07^>ZU$'> 'IU/^>A$&<_7X4@]W03?VX%V2S0%K
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M&N>5"&*QP@@(!#T"3B0S_"EP$H.&B":&(5!P) +88Q0=1B2%4%@0?TH@E6X
M?7>O"0JAD@V@[E@[I%V8&26(:AW+I#C'VKN08D-(>#+4R!"R)YH030NC45A$
M2#0ME!Y!B#: ;@8G<-<;9@04L@EAA1A 338<$ \[1X@9@TF!8.$Z,!(2A8+@
M<' 4!HO#H79#T$@4&H'DOC@8"D/ X@AH7<AW@7*S,<D!!"=SR^^YN)H!]/NF
MHJ*BX%$Z< 8S$('"X_$;,=!H&!<!BXBALXC1,'J$RH\(YI0($I,:QJ(RZ) -
MG>C/8+,,H- ?6Z"%V=G]#/S_=HM&0_Q 1["<* '_CHYPB0FC()PH$0PVDT3A
MPE5^2?7OU!] ,NDG+HS-#-W<)YF$H(12:!0Z*X*+16UBN943S!DD]H;5QMP
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M'"O9J%AE??@_4$L! A0#%     @ P8(,3YI4 !YB P  )0P  !
M     ( !     &-V<RTR,#$Y,#@P."YX<V102P$"% ,4    " #!@@Q/,)FB
MZV,&  !'1   %               @ &0 P  8W9S+3(P,3DP.# X7VQA8BYX
M;6Q02P$"% ,4    " #!@@Q/E60ZF[D$   &*P  %               @ $E
M"@  8W9S+3(P,3DP.# X7W!R92YX;6Q02P$"% ,4    " #!@@Q/T2HFBGL0
M  "S;   #@              @ $0#P  9#<Y,#4U-V0X:RYH=&U02P$"% ,4
M    " #!@@Q/!<E?%A=I  !OB ( $               @ &W'P  9#<Y,#4U
M-V1E>#$Q+FAT;5!+ 0(4 Q0    ( ,&"#$_)5OA59@X  % 0   /
M      "  ?R(  !G-SDP-34W:6TP,2YJ<&=02P4&      8 !@!Y 0  CY<
#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
